Biological
Keyhole-Limpet Hemocyanin
Keyhole-Limpet Hemocyanin is a biological therapy with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
1
20%
Ph phase_1
1
20%
Ph not_applicable
3
60%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
3(60.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Other(2)
Detailed Status
Completed3
unknown2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (20.0%)
Phase 41 (20.0%)
N/A3 (60.0%)
Trials by Status
unknown240%
completed360%
Recent Activity
0 active trials
Showing 5 of 5
unknownnot_applicable
KLH Challenge to Explore the Human Immune Response
NCT05876195
completednot_applicable
Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs
NCT00050921
completedphase_1
Safety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SC
NCT00026624
completednot_applicable
Keyhole Limpet Hemocyanin in Chronic Hepatitis C
NCT01509391
unknownphase_4
Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
NCT00005000
Clinical Trials (5)
Showing 5 of 5 trials
NCT05876195Not Applicable
KLH Challenge to Explore the Human Immune Response
NCT00050921Not Applicable
Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs
NCT00026624Phase 1
Safety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SC
NCT01509391Not Applicable
Keyhole Limpet Hemocyanin in Chronic Hepatitis C
NCT00005000Phase 4
Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
All 5 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 5